DDX3X and cancer: There is evidence that the inhibition of DDX3 functions by RK-33 could disrupt the DDX3-β-catenin complex and cause a disturbance in the Wnt signaling pathway involved in cell differentiation, cell proliferation, malignant tumors, and transition of the G1/S cell cycle [131].